Copyright © 1998 by the European Society of Cardiology.
Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms
Coronary Artery Disease Research Group, Department of Cardiological Sciences, St. George’s Hospital Medical School, London, U.K.
accepted June 20, 1997
Aims
We investigated patients with chest pain and normal coronary angiograms to determine whether low dose imipramine prescribed as add-on therapy to conventional anti-anginals reduced the incidence of chest pain and whether this led to an overall improvement in quality of life.
Methods and results
We performed a randomized, double-blind, cross-over trial of imipramine 50mg daily vs placebo in 18 women (median age 53 years; range 35–72) with chest pain and normal coronary angiograms who were suffering at least two anginal episodes per week despite conventional anti-anginal medication. Each treatment phase lasted 5 weeks and the incidences of chest pain and side effects were carefully recorded. Quality of life was monitored using a validated health profile questionnaire scoring perceived distress in six domains (pain, energy, mobility, sleep, emotional reactions and social isolation). The total number of chest pain episodes was significantly less during active treatment compared to placebo [11 (3–22) vs 21 (16–28)—median (interquartile range); P=0·01]. However, a high incidence (83%) of side effects was reported during active treatment and three patients had to be withdrawn from the study as a consequence. No significant improvement was detected in any of the six quality of life domains when imipramine was compared to placebo.
Conclusion
Imipramine reduces the incidence of chest pain in patients with chest pain and normal coronaries who remain symptomatic despite conventional anti-anginal therapy. The failure to demonstrate associated improvements in quality of life may have been due to the high incidence of side effects.
Key Words: Imipramine • angina with normal coronaries • quality of life
f1 Correspondence: Dr J. C. Kaski, Coronary Artery Disease Research Group, Department of Cardiological Sciences, St George’s Hospital Medical School, Cranmer Terrace, Tooting, London SW17 0RE.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H Jones, P Cooper, V Miller, N Brooks, and P J Whorwell Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy Gut, October 1, 2006; 55(10): 1403 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J C Kaski Cardiac syndrome X in women: the role of oestrogen deficiency Heart, May 1, 2006; 92(suppl_3): iii5 - iii9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Kaski Overview of gender aspects of cardiac syndrome X Cardiovasc Res, February 15, 2002; 53(3): 620 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Kaski and L. F. Valenzuela Garcia Therapeutic options for the management ofpatients with cardiac syndrome X Eur. Heart J., February 2, 2001; 22(4): 283 - 293. [PDF]
|
|